Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. | 3,000 | reported | 15 Oct 2025 | tx 4+280,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Oct 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 3,000 | 0.00 USD | deriv |
| 16 May 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 250,000 | 0.00 USD | |
| 14 May 2025 | PURCHASE | Apimeds Pharmaceuticals US, Inc. | 7,730 | 1.86 USD | |
| 13 May 2025 | PURCHASE | Apimeds Pharmaceuticals US, Inc. | 19,770 | 1.82 USD |